前收市價 | 0.5500 |
開市 | 0.4500 |
買盤 | 0.4000 |
賣出價 | 0.6000 |
拍板 | 8.00 |
到期日 | 2024-06-28 |
今日波幅 | 0.2500 - 0.4900 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 508 |
New data indicate that its cell therapy could soon find a larger market.
Iovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its combination therapy achieved an objective response rate of 65% in frontline advanced melanoma.
These biotech stocks have just launched their first products.